Could a shot every 6 months replace daily HIV pills? new trial aims to find out.

NCT ID NCT07054931

Recruiting now Disease control Sponsor: University of Oxford Source: ClinicalTrials.gov ↗

First seen Nov 01, 2025 · Last updated May 15, 2026 · Updated 28 times

Summary

This study tests a new approach for people with HIV: combining a vaccine with powerful antibodies (bNAbs) that may control the virus for months. Participants will stop their daily HIV pills for a short time to see if the combo can keep the virus in check. The goal is to find a way to reduce or replace lifelong daily medication.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIV are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Centre for Clinical Vaccinology and Tropical Medicine (CCVTM)
RECRUITING

Oxford, OX3 7LJ, United Kingdom

Contact Phone: •••-•••-•••• Email: •••••@•••••
Guys and St Thomas' NHS Trust
RECRUITING

London, SE1 7EH, United Kingdom

Contact Phone: •••-•••-•••• Email: •••••@•••••
St Mary's Clinical Trial Unit
RECRUITING

London, W2 1NY, United Kingdom

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

HIV